Can “Legal Highs” Trigger Myocardial Infarction? Patients' Characteristics Based on Published Cases

References

• CBOS. (2011). Opinie i diagnozy. Młodzież 2010. Retrieved 8 17, 2016, from www.cinn.gov.pl/portal?id = 15&res_id = 301553
   Google Scholar
• CBOS. (2014). Młodzież 2013. Retrieved 8 17, 2016, from www.cinn.gov.pl/portal?id = 15&res_id = 673746
   Google Scholar
• CBOS, & KBSPN. (2009). Młodzież a substancje psychoaktywne. Komunikat z badań. Retrieved 8 17, 2016, from www.cbos.pl/SPISKOM.POL/2009/K_011_09.PDF
   Google Scholar
• EMCDDA. (2015). European Drug Report, Trends and developments. Lisbon.
   Google Scholar
• UNODC. (2011). Synthetic cannabinoids in herbal products. Retrieved 8 8, 2016, from http://www.undoc.org/documents/scientific/Synthetic_Cannabinoids.pdf
   Google Scholar
• Adamowicz, P., Gieroń, J., Gil, D., Lechowicz, W., Skulska, A., & Tokarczyk, B. (2016). The prevalence of new psychoactive substances in biological material - a three-source review of casework in Poland. Drug Testing and Analysis, 8, 63–70.
   Google Scholar
• Al-Motarreb, A., & Broadley, K. (2003). Coronary and aortic vasoconstriction by cathinone, the active constituent of khat. Autonomic and Autacoid Pharmacology, 23, 319–326.
   Google Scholar
• Al-Motarreb, A., Briancon, S., Al-Jaber, N., Al-Adhi, B., Al-Jailani, F., Salek, M., & Broadley, K. (2005). Khat chewing is a risk factor for acute myocardial infarction:a case-control study. British Journal of Clinical Pharmacology, 59, 574–581.
   Google Scholar
• Aryana, A., & Williams, M. (2007). Marijuana as a trigger of cardiovascular events: Speculation or scientific certainty? International Journal of Cardiology, 118, 141–144.
   Google Scholar
• Atik, S., Dedeoglu, R., Valor, F., Cam, H., Eroglu, A., & Saltik, L. (2015). Cardiovascular side effects related with use of “Bonzai”: Two case reports. Turkish Archives of Pediatrics, 50, 61–64.
   Google Scholar
• Bonnici, K., Dargan, P., & Wood, D. (2015). Novel psychoactive substances or ‘legal highs’. British Journal of Hospital Medicine (London), 76, C130–C134.
   Google Scholar
• Castaneto, M., Gorelick, D., Desrosiers, N., Hartman, R., Pirard, S., & Huestis, M. (2014). Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug and Alcohol Dependence, 144, 12–41.
   Google Scholar
• CESAR FAX. (2013). Center for Substance Abuse Research. Synthetic Marijuana third most reported substance used by U.S. high school students. Retrieved 8 16, 2016, from http://www.cerar.umd.edu/cesar/cesarfax/vol22/22-17.pdf
   Google Scholar
• Flash Eurobarometer 401; TNS Political & Social. (2014). Young People and Drugs. Retrieved 8 9, 2016, from ec.europa.eu/public_opinion/flash/fl_401_en.pdf
   Google Scholar
• Jabłoński, P., & Malczewski, A. (2014). “Dopalacze” - skala zjawiska i przeciwdziałanie. Warszawa: Krajowe Biuro ds Przeciwdziałania Narkomanii.
   Google Scholar
• Karila, L., Megarbane, B., Cottenci, O., & Lejoyeux, M. (2015). Synthetic cathinones: A new public health problem. Current Neuropharmacology, 13, 12–20.
   Google Scholar
• Lavelle, S. (2016). Designer drugs and the impact on the adolescent user. Archives of Psychiatric Nursing, 30, 447–448.
   Google Scholar
• Liveri, K., Constantinou, M., Afxentiou, M., & Kanari, P. (2016). A fatal intoxication related to MDPV and pentedrone combined with antipsychotic and antidepressant substances in Cyprus. Forensic Science International, 265, 160–165.
   Google Scholar
• Mazurkiewicz, M., Głogowski, M., Mrowiński, D., Pakulski, M., Matyjaszczyk, M., & Kardas, P. (2013). Ocena rozpowszechnienia, powodów i form użycia tak zwanych “dopalaczy” przez uczestników ankiety internetowej. Psychiatria Polska, 47, 1143–1155.
   Google Scholar
• McIlroy, G., Ford, L., & Khan, J. (2016). Acute myocardial infarction, associated with the use of a synthetic adamantyl-cannabinoid: A case report. BMC Pharmacology and Toxicology, 17, 2.
   Google Scholar
• McKeever, R., Vearrier, D., Jacobs, D., LaSala, G., Okaneku, J., & Greenberg, M. (2015). K2 - not the spice of life, synthetic cannabinoids and ST elevation myocardial infarction: A case report. Journal of Medical Toxicology, 11, 129–131.
   Google Scholar
• Mir, A., Obafemi, A., Young, A., & Kane, C. (2011). Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics, 128, e1622–e1627.
   Google Scholar
• Mittleman, M., Lewis, R., Maclure, M., Sherwood, J., & Muller, J. (2001). Triggering Myocardial Infarction by Marijuana. Cirrculation, 103, 2805–2809.
   Google Scholar
• Odoardi, S., Romolo, F., & Strano-Rossi, S. (2016). A snapshot on NPS in Italy: Distribution of drugs in seized materials analysed in an Italian forensic laboratory in period 2013–2015. Forensic Science International, 265, 116–120.
   Google Scholar
• Orsini, J., Blaak, C., Tam, E., Rajayer, S., Morante, J., Yeh, A., & Butala, A. (2015). The wide and unpredictible scope of synthetic cannabinoids toxicity. Case Reports in Critical Care, 2015, 542490.
   Google Scholar
• Ozkan, H., Cetinkaya, A., Ari, H., Tiryakioglu, S., & Bozat, T. (2015). Endothelial dissection due to the usage of synthetic cannabinoid: Bonsai. American Journal of Cardiology, 115 SUPL. 1, S100–S101.
   Google Scholar
• Państwowa Inspekcja Sanitarna. (2015). Raport Głównego Inspektora Sanitarnego w sprawie środków zastępczych - razem przeciwko dopalaczom 2013–2014. Warszawa: Głowny Inspektor Sanitarny.
   Google Scholar
• Sarkar, A., Pande, A., Naveen Chandra, G., & Ahmed, I. (2013). Acute myocardial infarction in a young cocaine addict with normal coronaries: Time to raise awareness among emergency physicians. Indian Journal of Critical Care Medicine, 17, 56–58.
   Google Scholar
• Sherpa, D., Paudel, B., Subedi, B., & Chow, R. (2015). Synthetic cannabinoids: the multi-organ failure and metabolic derangements associated with getting high. Journal of Community Hospital Internal Medicine Perspectives, 5, 27540.
   Google Scholar
• Sinha, A., Lewis, O., Kumar, R., Yeruva, S., & Curry, B. (2016). Amphetamine abuse related acute myocardial infarction. Case Reports in Cardiology, 2016, 7967851.
   Google Scholar
• Tait, R., Caldicott, D., Mountain, D., Hill, S., & S, L. (2016). A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clinical Toxicology (Philadelphia), 54, 1–13.
   Google Scholar
• Tatli, E., & Aktoz, M. (2010). Heroine abuse and myocardial infarction. Medical Journal of Trakya University, 27, 212–214.
   Google Scholar
• Troendle, M., Stromberg, P., & Rose, S. (2013). Survival despite severe hyperthermia and multiorgan system dysfunction following week-long use of MDPV containing “stain remover.” Clinical Toxicology, 51, 679–680.
   Google Scholar
• Tse, R., Kodur, S., Squires, B., & Collins, N. (2014). Sudden cardiac death complicating acute myocardial infarction following synthetic cannabinoid use. Internal Medicine Journal, 44, 934–936.
   Google Scholar
• Varma, D., & Dalal, P. (2012). “K2,” “spice,” and “bath salts”—The in-vogue recreational drugs—what the intensivists need to know. Chest, 142(4_MeetingAbstracts), 340A.
   Google Scholar
• Velibey, Y., Sahin, S., Tanik, O., Keskin, M., Bolca, O., & Eren, M. (2015). Acute myocardial infarction due to marijuana smoking in young man: Guilty should not be underestimated. American Journal of Emergency Medicine, 33, 1114.e1–e3.
   Google Scholar
• Walsh, J., Harris, B., & Ossei-Gerning, N. (2015). MI with multiple distal occlusions associated with use of the synthetic cannabinoids 5F-AKB48. The British Journal of Cardiology, 22, 40.
   Google Scholar
• Werner, R., Chowdhury, N., & Smalligan, R. (2013). When adding spice can threaten life. Journal of General Internal Medicine, 28 SUPL. 1, S422.
   Google Scholar
• Yılmaz, S., Ünal, S., Kuyumcu, M., Balcı, K., & Balcı, M. (2015). Acute anterior myocardial infarction after “Bonzai” use. The Anatolian Journal of Cardiology, 15, 265–266.
   Google Scholar
• Zaleta, S., Kumar, P., & Miller, S. (2016). Chest pain, troponin rise, and ST-elevation in an adolescent boy following the use of the synthetic cannabis product K2. Annals of Pediatric Cardiology, 9, 79–81.
   Google Scholar